MétaCan
Menu
← Back to cohort

Subgroup Analysis By Race in Perampanel Phase III Clinical Studies (P1.254)

2015· article· en· W1821800984 on OpenAlexaboutno aff
Antonio Laurenza, Haichen Yang, Betsy Williams, Steven J.T. Huang, Michael R. Sperling

Bibliographic record

VenueNeurology · 2015
Typearticle
Languageen
FieldMedicine
TopicEpilepsy research and treatment
Canadian institutionsnot available
Fundersnot available
KeywordsPerampanelRace (biology)Subgroup analysisPhase (matter)PsychologyMedicineEpilepsySociologyInternal medicineNeurosciencePhysicsGender studiesMeta-analysis

Abstract

fetched live from OpenAlex

Objective: To evaluate potential differences in perampanel efficacy/safety based on race from pooled Phase III partial seizure clinical studies. Background: Perampanel is approved for adjunctive treatment of partial seizures in >40 countries. Pharmacokinetic properties of antiepileptic drugs (AEDs) can be affected by race/ethnicity.1 Desing/Methods: Patients (aged蠅12years) with refractory partial seizures receiving 1-3 concomitant AEDs enrolled in 3 double-blind Phase III studies were randomized to 19-weeks (6-week titration/13-week maintenance) of once-daily perampanel 2,4,8 or 12mg or placebo treatment. Patients were recruited from US, Canada, Australia and countries in Latin America, Africa, Asia and Europe. Pooled results (n=1478) were grouped by patient race: White (n=1114), Asian/Pacific-Islander (n=289 [Chinese: n=112]), Other (n=44), Black/African-American (n=31). Study endpoints included population pharmacokinetic and pharmacokinetic/pharmacodynamic analyses, percent change from baseline in seizure frequency/28 days, responder rate and safety. Due to small patient numbers in Black/African-American and Other subgroups, efficacy/safety analyses based on race compare Whites and Asian/Pacific-Islanders only. Results: In the population pharmacokinetic model developed for perampanel based on plasma concentrations from the Phase III studies, there was no significant difference in perampanel clearance or in concentration-response relationship for perampanel as a function of race. Improved seizure control was seen for perampanel therapeutic doses (4-12mg) compared to placebo in White and Asian/Pacific-Islander subgroups. Very common treatment-emergent adverse events (TEAEs) included dizziness, somnolence, headache, fatigue, irritability and fall, with no notable differences in TEAEs based on race. Patient study discontinuation proportion was similar among Whites (perampanel 16.8[percnt] vs placebo 10.1[percnt]) and Asian/Pacific-Islanders (perampanel 12.7[percnt] vs placebo 10.4[percnt]). Conclusions: Perampanel pharmacokinetics were similar between Whites and Asians/Pacific-Islanders, with improved seizure control observed for both subgroups. Incidence of very common TEAEs was also comparable. Sample size of Black/African-American or Other subgroups was too small to determine if efficacy or safety were different in these subgroups. Reference:1.Faught.Epilepsia2001;42(Supp4):19. Support: Eisai Inc.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.028
metaresearch head score (Gemma)0.030
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.028
Threshold uncertainty score0.149

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0280.030
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0060.019
Bibliometrics0.0020.002
Science and technology studies0.0000.000
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.148
GPT teacher head0.474
Teacher spread0.326 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueNeurology→Same topicEpilepsy research and treatment→French-language works237,207→